实施一项促进肾移植受者术后恢复(ERAS)的综合方案可改善患者和移植物的预后。

IF 1.9 4区 医学 Q2 SURGERY Clinical Transplantation Pub Date : 2024-12-31 DOI:10.1111/ctr.70056
Mohamed Eltemamy, Paul J. Oh, Hafiz Umair Siddiqui, Yi-Chia Lin, M. Cecilia Lansang, Emilio Poggio, David Goldfarb, Venkatesh Krishnamurthi, Alvin Wee
{"title":"实施一项促进肾移植受者术后恢复(ERAS)的综合方案可改善患者和移植物的预后。","authors":"Mohamed Eltemamy,&nbsp;Paul J. Oh,&nbsp;Hafiz Umair Siddiqui,&nbsp;Yi-Chia Lin,&nbsp;M. Cecilia Lansang,&nbsp;Emilio Poggio,&nbsp;David Goldfarb,&nbsp;Venkatesh Krishnamurthi,&nbsp;Alvin Wee","doi":"10.1111/ctr.70056","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Enhanced recovery after surgery (ERAS) protocols have gained widespread acceptance as a means to enhance surgical outcomes. However, the intricate care required for kidney transplant recipients has not yet led to the establishment of a universally recognized and dependable ERAS protocol for kidney transplantation.</p>\n </section>\n \n <section>\n \n <h3> Objective</h3>\n \n <p>We devised a customized ERAS protocol to determine its effectiveness in improving surgical and postoperative outcomes among kidney transplant recipients.</p>\n </section>\n \n <section>\n \n <h3> Design, Setting, and Participants</h3>\n \n <p>This was a retrospective, single-center study performed at our tertiary care institution. Three hundred and fifty-six patients in the conventional group (from January 1, 2015 to December 31, 2017) and 442 patients from the ERAS group (from January 1, 2018 to June 1, 2020) were compared. Patients were followed for 1 year postoperatively.</p>\n </section>\n \n <section>\n \n <h3> Intervention</h3>\n \n <p>Changes were made in the preoperative, operative, postoperative, and outpatient follow-up settings after transplantation.</p>\n </section>\n \n <section>\n \n <h3> Outcome Measurements and Statistical Analysis</h3>\n \n <p>Primary endpoints were hospital length of stay (LOS) and 30-day readmission rates. We also measured surgical outcomes, graft performance, and patient survival. Wilcoxon rank-sum, Pearson's Chi-squared, or Fisher's exact tests were used to compare groups.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Our ERAS protocol was associated with a decrease in hospital LOS from 5 to 3 days (<i>p</i> &lt; 0.001) and 57.1% lower odds of hospital readmissions within 30 days compared to the conventional group (<i>p</i> &lt; 0.001, 95% CI 0.26–0.7). Decreases in operative estimated blood loss, blood transfusion rates, and delayed graft function were also associated with the ERAS protocol.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Our multi-layered ERAS protocol is effective in improving outcomes for kidney transplant recipients. A future multi-institutional study with healthcare savings analysis may suggest that widespread benefits are yet to be realized by the greater implementation of such enhanced recovery protocols.</p>\n </section>\n </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"39 1","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Implementation of a Comprehensive Protocol for Enhanced Recovery After Surgery (ERAS) in Kidney Transplant Recipients Improves Patient and Graft Outcomes\",\"authors\":\"Mohamed Eltemamy,&nbsp;Paul J. Oh,&nbsp;Hafiz Umair Siddiqui,&nbsp;Yi-Chia Lin,&nbsp;M. Cecilia Lansang,&nbsp;Emilio Poggio,&nbsp;David Goldfarb,&nbsp;Venkatesh Krishnamurthi,&nbsp;Alvin Wee\",\"doi\":\"10.1111/ctr.70056\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Enhanced recovery after surgery (ERAS) protocols have gained widespread acceptance as a means to enhance surgical outcomes. However, the intricate care required for kidney transplant recipients has not yet led to the establishment of a universally recognized and dependable ERAS protocol for kidney transplantation.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Objective</h3>\\n \\n <p>We devised a customized ERAS protocol to determine its effectiveness in improving surgical and postoperative outcomes among kidney transplant recipients.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Design, Setting, and Participants</h3>\\n \\n <p>This was a retrospective, single-center study performed at our tertiary care institution. Three hundred and fifty-six patients in the conventional group (from January 1, 2015 to December 31, 2017) and 442 patients from the ERAS group (from January 1, 2018 to June 1, 2020) were compared. Patients were followed for 1 year postoperatively.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Intervention</h3>\\n \\n <p>Changes were made in the preoperative, operative, postoperative, and outpatient follow-up settings after transplantation.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Outcome Measurements and Statistical Analysis</h3>\\n \\n <p>Primary endpoints were hospital length of stay (LOS) and 30-day readmission rates. We also measured surgical outcomes, graft performance, and patient survival. Wilcoxon rank-sum, Pearson's Chi-squared, or Fisher's exact tests were used to compare groups.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Our ERAS protocol was associated with a decrease in hospital LOS from 5 to 3 days (<i>p</i> &lt; 0.001) and 57.1% lower odds of hospital readmissions within 30 days compared to the conventional group (<i>p</i> &lt; 0.001, 95% CI 0.26–0.7). Decreases in operative estimated blood loss, blood transfusion rates, and delayed graft function were also associated with the ERAS protocol.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Our multi-layered ERAS protocol is effective in improving outcomes for kidney transplant recipients. A future multi-institutional study with healthcare savings analysis may suggest that widespread benefits are yet to be realized by the greater implementation of such enhanced recovery protocols.</p>\\n </section>\\n </div>\",\"PeriodicalId\":10467,\"journal\":{\"name\":\"Clinical Transplantation\",\"volume\":\"39 1\",\"pages\":\"\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Transplantation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/ctr.70056\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Transplantation","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ctr.70056","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

摘要

背景:增强术后恢复(ERAS)方案作为提高手术效果的手段已被广泛接受。然而,肾移植受者所需的复杂护理尚未导致建立一个普遍认可和可靠的肾移植ERAS协议。目的:我们设计了一个定制的ERAS方案,以确定其在改善肾移植受者手术和术后预后方面的有效性。设计、环境和参与者:这是一项在我们三级医疗机构进行的回顾性单中心研究。对常规组356例患者(2015年1月1日至2017年12月31日)和ERAS组442例患者(2018年1月1日至2020年6月1日)进行比较。术后随访1年。干预措施:移植后术前、手术、术后和门诊随访设置发生改变。结果测量和统计分析:主要终点是住院时间(LOS)和30天再入院率。我们还测量了手术结果、移植物性能和患者生存率。使用Wilcoxon秩和、Pearson卡方或Fisher精确检验进行组间比较。结果:我们的ERAS方案可降低5 - 3天的住院LOS (p)。结论:我们的多层ERAS方案可有效改善肾移植受者的预后。未来的多机构研究与医疗节约分析可能表明,广泛的效益尚未实现更大的实施这种增强恢复协议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Implementation of a Comprehensive Protocol for Enhanced Recovery After Surgery (ERAS) in Kidney Transplant Recipients Improves Patient and Graft Outcomes

Background

Enhanced recovery after surgery (ERAS) protocols have gained widespread acceptance as a means to enhance surgical outcomes. However, the intricate care required for kidney transplant recipients has not yet led to the establishment of a universally recognized and dependable ERAS protocol for kidney transplantation.

Objective

We devised a customized ERAS protocol to determine its effectiveness in improving surgical and postoperative outcomes among kidney transplant recipients.

Design, Setting, and Participants

This was a retrospective, single-center study performed at our tertiary care institution. Three hundred and fifty-six patients in the conventional group (from January 1, 2015 to December 31, 2017) and 442 patients from the ERAS group (from January 1, 2018 to June 1, 2020) were compared. Patients were followed for 1 year postoperatively.

Intervention

Changes were made in the preoperative, operative, postoperative, and outpatient follow-up settings after transplantation.

Outcome Measurements and Statistical Analysis

Primary endpoints were hospital length of stay (LOS) and 30-day readmission rates. We also measured surgical outcomes, graft performance, and patient survival. Wilcoxon rank-sum, Pearson's Chi-squared, or Fisher's exact tests were used to compare groups.

Results

Our ERAS protocol was associated with a decrease in hospital LOS from 5 to 3 days (p < 0.001) and 57.1% lower odds of hospital readmissions within 30 days compared to the conventional group (p < 0.001, 95% CI 0.26–0.7). Decreases in operative estimated blood loss, blood transfusion rates, and delayed graft function were also associated with the ERAS protocol.

Conclusion

Our multi-layered ERAS protocol is effective in improving outcomes for kidney transplant recipients. A future multi-institutional study with healthcare savings analysis may suggest that widespread benefits are yet to be realized by the greater implementation of such enhanced recovery protocols.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical Transplantation
Clinical Transplantation 医学-外科
CiteScore
3.70
自引率
4.80%
发文量
286
审稿时长
2 months
期刊介绍: Clinical Transplantation: The Journal of Clinical and Translational Research aims to serve as a channel of rapid communication for all those involved in the care of patients who require, or have had, organ or tissue transplants, including: kidney, intestine, liver, pancreas, islets, heart, heart valves, lung, bone marrow, cornea, skin, bone, and cartilage, viable or stored. Published monthly, Clinical Transplantation’s scope is focused on the complete spectrum of present transplant therapies, as well as also those that are experimental or may become possible in future. Topics include: Immunology and immunosuppression; Patient preparation; Social, ethical, and psychological issues; Complications, short- and long-term results; Artificial organs; Donation and preservation of organ and tissue; Translational studies; Advances in tissue typing; Updates on transplant pathology;. Clinical and translational studies are particularly welcome, as well as focused reviews. Full-length papers and short communications are invited. Clinical reviews are encouraged, as well as seminal papers in basic science which might lead to immediate clinical application. Prominence is regularly given to the results of cooperative surveys conducted by the organ and tissue transplant registries. Clinical Transplantation: The Journal of Clinical and Translational Research is essential reading for clinicians and researchers in the diverse field of transplantation: surgeons; clinical immunologists; cryobiologists; hematologists; gastroenterologists; hepatologists; pulmonologists; nephrologists; cardiologists; and endocrinologists. It will also be of interest to sociologists, psychologists, research workers, and to all health professionals whose combined efforts will improve the prognosis of transplant recipients.
期刊最新文献
Flying Kidneys or Flying Donors: What Do Prior Canadian Living Kidney Donors Think? Individual Association of Predicted Left and Right Ventricular Mass Ratios With Survival After Heart Transplantation: A UNOS Database Analysis Liver Transplant Fast-Track With an Emphasis on Reduced Delirium: A Multidisciplinary Approach to Reducing Length of Stay Hybrid Telemedicine and In-Person Care for Kidney Transplant Follow-Up: A Qualitative Study Is Survival Impacted by One or Several Successive Cancers After Liver Transplantation? A French National Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1